Strategic development projects
IN IMMUNOLOGY
- Ongoing project to apply for marketing authorisation in the United States.
- Development of a new route of administration.
IN HAEMOSTASIS
- Ongoing clinical development to extend indications in the United States.
- Marketing authorisation requests planned in Colombia and Algeria.
IN INTENSIVE CARE:
- Ongoing clinical development to extend indications in Europe.
- Ongoing project to apply for marketing authorisation in the United States.
- Development of a new dosage strength.
The LFB group is conducting several clinical trials in order to register its products, in the fields of immunology, haemostasis and intensive care.
For more information on clinical trials of the products under development, please refer to the following websites:
- International Clinical Trial Registry Platform : http://apps.who.int/trialsearch/
- In United States: https://clinicaltrials.gov/
- In Europe: https://www.clinicaltrialsregister.eu/
Job Code: NP-25/10/001 – Date of preparation: November 2025